EP3655017
Lyfjasamsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.7.2018EP published:
22.1.2025EP application number:
18759254.8
EP translation filed:
19.3.2025Grant published:
15.4.2025EPO information:
European Patent Register
Max expiry date:
16.7.2038Expiry date:
16.7.2026Next due date:
31.7.2026
Title in English:
PHARMACEUTICAL COMPOSITIONLanguage of the patent:
English
Timeline
Today
17.7.2018EP application
22.1.2025EP Publication
19.3.2025Translation submitted
15.4.2025Registration published
16.7.2026Expires
Owner
Name:
MEDINCELL S.A.Address:
3 Rue des Frères Lumière, 34830 Jacou, FR
Inventor
Name:
ROBERGE, ChristopheAddress:
F-34830 Jacou, FR
Name:
RECH, AnthonyAddress:
F-34830 Jacou, FR
Name:
CROS, Jean-ManuelAddress:
F-34830 Jacou, FR
Name:
ABBASSI, MyriamAddress:
F-34830 Jacou, FR
Name:
LÓPEZ-NORIEGA, AdolfoAddress:
F-34830 Jacou, FR
Name:
PEBREL, LeaAddress:
F-34830 Jacou, FR
Name:
PETIT, AudreyAddress:
F-34830 Jacou, FR
Name:
SERINDOUX, JulietteAddress:
F-34830 Jacou, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762533370 PDate:
17.7.2017Country:
US
Classification
Categories:
A61K 9/00, A61K 9/06, A61K 31/445, A61K 31/519, A61K 31/7048, A61K 38/08, A61K 47/34, A61K 31/5415, C08G 63/664, C08L 67/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 29.7.2025
Expires: 16.7.2026
Payer: Árnason Faktor ehf.